Endurant Capital Management’s CONMED CNMD Stock Holding History

Endurant Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-41,984	Closed	-$4.23M	–	36
2023 Q3	$4.23M	Buy	+41,984	New	+$4.82M	3.8%	9
2020 Q4	–	Sell	-81,205	Closed	-$6.39M	–	59
2020 Q3	$6.39M	Buy	+81,205	New	+$6.62M	1.89%	14
2020 Q1	–	Sell	-17,940	Closed	-$2.01M	–	58
2019 Q4	$2.01M	Buy	17,940 +4,828	+37%	+$515K	0.63%	34
2019 Q3	$1.26M	Buy	+13,112	New	+$1.23M	0.45%	36
2017 Q3	–	Sell	-18,700	Closed	-$953K	–	89
2017 Q2	$953K	Sell	18,700 -8,400	-31%	-$416K	0.27%	70
2017 Q1	$1.2M	Buy	+27,100	New	+$1.17M	0.39%	62
2016 Q4	–	Sell	-39,500	Closed	-$1.58M	–	79
2016 Q3	$1.58M	Buy	+39,500	New	+$1.68M	0.59%	40
2016 Q2	–	Sell	-28,090	Closed	-$1.18M	–	91
2016 Q1	$1.18M	Buy	+28,090	New	+$1.1M	0.38%	53

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Endurant Capital Management's CNMD Position: Q4 2023 in Review

Endurant Capital Management sold out of CONMED (CNMD) in Q4 2023, closing a stake of 41,984 shares — an estimated $4.23M sold.

Endurant Capital Management first reported a position in CNMD in Q1 2016 and held it in 8 quarters. The position peaked at $6.39M in Q3 2020. 306 funds tracked by Wall St. Rank hold CNMD as of Q4 2023.

Endurant Capital Management reported no remaining CONMED position as of Q4 2023 after selling out during the quarter.
Endurant Capital Management sold 41,984 CONMED shares in Q4 2023, an estimated $4.23M.
Endurant Capital Management first reported a position in CONMED in Q1 2016 and held it in 8 quarters.
Endurant Capital Management's CONMED position peaked at $6.39M in Q3 2020.
306 funds tracked by Wall St. Rank held CONMED as of Q4 2023.

Based on Endurant Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.